Mesa Laboratories Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	26.93	27.32	28.21	32.91	49.35
Cash & Short-Term Investments	26.93	27.32	28.21	32.91	49.35
Cash Growth	-1.44%	-3.16%	-14.27%	-33.31%	-81.30%
Accounts Receivable	44.1	41.97	39.06	42.55	41.22
Inventory	26.37	25.37	32.68	34.64	24.61
Other Current Assets	8.87	8.03	9.41	8.87	9.14
Total Current Assets	106.27	102.69	109.35	118.98	124.32
Net Property, Plant & Equipment	30.61	32.33	31.77	28.15	28.62
Other Intangible Assets	83.35	96.88	113.75	216.82	250.12
Goodwill	186.86	181.76	180.1	286.44	291.17
Other Long-Term Assets	20.66	19.7	11.83	1.08	13.15
Total Assets	427.75	433.35	446.8	661.83	707.37
Accounts Payable	4.93	5.75	6.04	6.13	7.9
Accrued Expenses	36.62	42.46	22.79	21.53	26.33
Current Portion of Long-Term Debt	5.63	101.05	-	-	-
Unearned Revenue	14.72	14.71	15.48	15.69	13.83
Total Current Liabilities	61.9	163.96	44.31	43.36	48.06
Long-Term Debt	145.86	76.9	221.7	183.27	218.37
Other Long-Term Liabilities	33.75	32.65	35.39	41.72	47.15
Total Long-Term Liabilities	179.6	109.56	257.09	224.99	265.51
Total Liabilities	241.5	273.52	301.4	268.35	313.57
Common Stock	375.35	358.54	343.64	332.08	313.46
Accumulated Other Comprehensive Income	-3.36	-9.78	-14.76	-12.8	3.67
Retained Earnings	-185.75	-188.94	-183.49	74.2	76.68
Shareholders' Equity	186.25	159.83	145.39	393.48	393.8
Total Liabilities & Equity	427.75	433.35	446.8	661.83	707.37
Total Debt	151.48	177.95	221.7	183.27	218.37
Net Cash (Debt)	-124.55	-150.63	-193.48	-150.36	-169.02
Net Cash Per Share	-22.38	-27.79	-35.92	-28.05	-31.68
Book Value	186.25	159.83	145.39	393.48	393.8
Book Value Per Share	33.47	29.48	26.99	73.40	73.81
Tangible Book Value	-83.97	-118.81	-148.46	-109.78	-147.48
Tangible Book Value Per Share	-15.09	-21.92	-27.56	-20.48	-27.64

SEC Filings: 10-K · 10-Q